| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 412,588 | 441,052 | 937,516 | 801,304 | | Cost of Revenue | 422,616 | 438,923 | 761,034 | 771,747 | | | Gross Profit | (10,028) | 2,129 | 176,482 | 29,557 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,804 | 18,019 | 89,919 |
-
| | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7,579 | 7,880 | 7,508 | 7,361 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (29,411) | (23,770) | 79,055 | 22,196 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,314 | 1,179 | 1,058 | 858 | | Earnings Before Interest And Taxes | (12,144) | (27,778) | 69,347 | 23,054 | | Interest Expense | 5,061 | 5,187 | 4,219 | 6,547 | | Income Before Tax | (33,158) | (27,778) | 75,894 | 16,507 | | Income Tax Expense | (12,808) | (12,146) | 28,197 | 5,245 | | Minority Interest |
-
|
-
| (514) | 514 | | | | Net Income From Continuing Ops | (18,863) | (14,155) | 48,484 | 11,776 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,863) | (14,155) | 48,484 | 11,776 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,863) | ($14,155) | $48,484 | $11,776 |
|
0.51% Nasdaq 
Income Statement
